These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26435454)

  • 21. Recent developments in ocular gene therapy.
    Borrás T
    Exp Eye Res; 2003 Jun; 76(6):643-52. PubMed ID: 12742346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic applications of ultrasound in ophthalmology.
    Aptel F; Lafon C
    Int J Hyperthermia; 2012; 28(4):405-18. PubMed ID: 22621741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular biomaterials and implants.
    Lloyd AW; Faragher RG; Denyer SP
    Biomaterials; 2001 Apr; 22(8):769-85. PubMed ID: 11246945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular drug delivery: molecules, cells, and genes.
    Liu X; Brandt CR; Rasmussen CA; Kaufman PL
    Can J Ophthalmol; 2007 Jun; 42(3):447-54. PubMed ID: 17508043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing vision loss in chronic eye disease.
    Fong A; Lee G
    Aust Fam Physician; 2009 Oct; 38(10):774-9. PubMed ID: 19893815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eye disease and the older diabetic.
    Tumosa N
    Clin Geriatr Med; 2008 Aug; 24(3):515-27, vii. PubMed ID: 18672186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. siRNA Therapeutics in Ocular Diseases.
    Moreno-Montañés J; Bleau AM; Martínez T; Vargas B; González MV; Jiménez AI
    Methods Mol Biol; 2021; 2282():417-442. PubMed ID: 33928588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
    Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
    Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug delivery to the posterior segment of the eye.
    Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
    Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between nuclear receptors and ocular diseases.
    Liu K; Zou C; Qin B
    Oncotarget; 2017 Apr; 8(16):27603-27615. PubMed ID: 28187442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways.
    Wong CW; Wong TY; Cheng CY; Sabanayagam C
    Kidney Int; 2014 Jun; 85(6):1290-302. PubMed ID: 24336029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol and Ophthalmic Diseases.
    Abu-Amero KK; Kondkar AA; Chalam KV
    Nutrients; 2016 Apr; 8(4):200. PubMed ID: 27058553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.
    Mandal A; Pal D; Agrahari V; Trinh HM; Joseph M; Mitra AK
    Adv Drug Deliv Rev; 2018 Feb; 126():67-95. PubMed ID: 29339145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular disease and driving.
    Wood JM; Black AA
    Clin Exp Optom; 2016 Sep; 99(5):395-401. PubMed ID: 27156178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.